What is the mechanism of action of NSAIDs and acetaminophen in migraine treatment?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

What is the mechanism of action of NSAIDs and acetaminophen in migraine treatment?

Prostaglandins drive migraine pain by promoting vasodilation and sensitizing trigeminal nociceptors. Blocking their production reduces this pain signaling. Nonsteroidal anti-inflammatory drugs do this by inhibiting cyclooxygenase enzymes COX-1 and COX-2, which lowers prostaglandin synthesis in peripheral tissues, reducing inflammation and nociceptor sensitization that contribute to migraine. Acetaminophen also lowers prostaglandin synthesis, but mainly within the central nervous system, and it has weak anti-inflammatory effects peripherally. Its analgesic effect in migraine is thought to come from central COX inhibition and possible modulation of pain pathways in the brain, rather than strong peripheral anti-inflammatory action. That shared mechanism—reducing prostaglandin production via COX inhibition— explains why these drugs can relieve migraine pain. Other options point to different drug classes: blocking CGRP receptors targets CGRP antagonists, not NSAIDs or acetaminophen; blocking serotonin reuptake and enhancing GABA transmission are mechanisms for other drug categories not typically governing acute NSAID/acetaminophen migraine relief.

Prostaglandins drive migraine pain by promoting vasodilation and sensitizing trigeminal nociceptors. Blocking their production reduces this pain signaling. Nonsteroidal anti-inflammatory drugs do this by inhibiting cyclooxygenase enzymes COX-1 and COX-2, which lowers prostaglandin synthesis in peripheral tissues, reducing inflammation and nociceptor sensitization that contribute to migraine.

Acetaminophen also lowers prostaglandin synthesis, but mainly within the central nervous system, and it has weak anti-inflammatory effects peripherally. Its analgesic effect in migraine is thought to come from central COX inhibition and possible modulation of pain pathways in the brain, rather than strong peripheral anti-inflammatory action.

That shared mechanism—reducing prostaglandin production via COX inhibition— explains why these drugs can relieve migraine pain. Other options point to different drug classes: blocking CGRP receptors targets CGRP antagonists, not NSAIDs or acetaminophen; blocking serotonin reuptake and enhancing GABA transmission are mechanisms for other drug categories not typically governing acute NSAID/acetaminophen migraine relief.

More practice questions